Amh Equity LTD Icad Inc Transaction History

Amh Equity LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$1.39 - $2.4 $221,578 - $382,581	-159,409 Reduced 53.84%	136,643 $250,000
Q3 2024 Nov 07, 2024	SELL	$1.19 - $1.74 $4,698 - $6,869	-3,948 Reduced 1.32%	296,052 $464,000
Q2 2024 Aug 06, 2024	BUY	$1.28 - $1.9 $219,136 - $325,280	171,200 Added 132.92%	300,000 $390,000
Q1 2024 May 06, 2024	BUY	$1.35 - $2.27 $173,880 - $292,376	128,800 New	128,800 $207,000
Q2 2023 Aug 01, 2023	SELL	$1.14 - $1.63 $86,440 - $123,594	-75,825 Reduced 62.77%	44,970 $73,000
Q1 2023 May 02, 2023	BUY	$1.2 - $2.84 $144,954 - $343,057	120,795 New	120,795 $149,000

7.09M

67K

40.2K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $88.2M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Amh Equity LTD, based on Form 13F filings with the SEC.

Stay updated on Amh Equity LTD with notifications on news.